A(z) Pharmaceutical csatorna legjobb podcastjai (2025)

1
Pharmaceutical Executive Daily: FDA Approves Breyanzi 1:43

3h ago1:43

1:43

In today’s Pharmaceutical Executive Daily, the FDA greenlights an expanded use of Breyanzi, Eli Lilly reports Jaypirca met its primary endpoint in a head-to-head Phase III trial against Imbruvica for CLL/SLL, and new analyses highlight how health systems are strengthening partnerships to support cell and gene therapy commercialization.…

1
How AI is Shaping the Future: The Rise of The Bionic Professional with Bill Wallace 42:50

3d ago42:50

42:50

How AI is Shaping the Future: The Rise of The Bionic Professional with Bill Wallace #aitechnology #futureofwork #bionicprofessional Step into the exciting world where AI is transforming the way we work and the very nature of our professions. Please visit our website to get more information: https://swangroup.net/ In this episode, I’m joined by Bill…

1
From Powder to Pill: The Art and Science of Pharmaceutical Manufacturing and Delivery 11:05

6d ago11:05

11:05

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
Episode 302: Name That Player 1:02:28

7d ago1:02:28

1:02:28

Clay, Stephen, and Valair discuss expectations, the 2026 schedule, and the MLS Cup final. We hope everyone had a wonderful Thanksgiving and thanks for listening!Pharmaceutical Soccer által

1
Pharmaceutical Executive Daily: Mark Cuban's Push for Generic Drug Fee Waivers 1:48

20h ago1:48

1:48

In today’s Pharmaceutical Executive Daily, former FDA commissioners caution that new vaccine policies could weaken long-established regulatory standards, Mark Cuban urges federal officials to waive fees to boost generic drug competition, and a new report reveals patients are increasingly avoiding care due to rising healthcare costs.…

1
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER 1:49

2d ago1:49

1:49

In today’s Pharmaceutical Executive Daily, the FDA appoints Tracy Beth Høeg as acting CDER director, health systems explore new commercialization partnerships for cell and gene therapies, and Aidoc submits a breakthrough-designated multi-triage AI device for FDA approval.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: FDA's Agentic AI Deployment 1:51

3d ago1:51

1:51

In today’s Pharmaceutical Executive Daily, Regeneron launches a $150 million gene editing collaboration with Tessera Therapeutics, the FDA begins agency-wide deployment of new agentic AI tools, and a new report suggests Richard Pazdur is stepping down as director of CDER.Pharmaceutical Executive Podcast által

1
Clinical Consequences and the Future of Transporter Science 10:08

6d ago10:08

10:08

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
Beyond P-glycoprotein: The MRP Family and BCRP in Drug Disposition 10:03

3d ago10:03

10:03

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
P-glycoprotein and Multidrug Resistance – The Body's Double-Edged Sword 8:42

3d ago8:42

8:42

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
The Basics of Drug Transporters – Gatekeepers of the Body 8:40

3d ago8:40

8:40

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
A Real-World Case and The Future of Drug Delivery 8:29

3d ago8:29

8:29

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
Modeling the Journey and Measuring the Destination 9:19

6d ago9:19

9:19

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
What is Targeted Bioavailability? 8:30

6d ago8:30

8:30

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
The Science of Shelf Life: Ensuring Drug Stability from Factory to Patient 9:28

6d ago9:28

9:28

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
The Foundation of Effective Medicines: Understanding Drug Solubility and Stability 9:26

6d ago9:26

9:26

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
Navigating the Gauntlet: How a Drug's Journey Begins 8:42

6d ago8:42

8:42

Unlock the potential of precision medicine with Creative Biolabs’ latest podcast. We dive deep into the science of drug delivery, exploring how targeted systems like nanoparticles and liposomes are revolutionizing therapy. Learn how these innovations ensure drugs reach their specific destinations, maximizing efficacy while minimizing toxicity. Perf…

1
Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound 1:49

4d ago1:49

1:49

In today’s Pharmaceutical Executive Daily, Eli Lilly reduces the price of Zepbound single-dose vials for self-pay patients, a new report claims the FDA is planning changes to its vaccine approval process following assertions of COVID vaccine–related deaths, and Korea and Australia reorient their pharma launch strategies toward broader regional mark…

1
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products 1:50

5d ago1:50

1:50

In today’s Pharmaceutical Executive Daily, Novo Nordisk files for FDA approval of a higher-dose Wegovy injectable using a priority review voucher, the US and UK agree to eliminate tariffs on pharmaceutical products, and CMS publishes major price cuts for 15 high-cost Medicare drugs under the latest IRA negotiation round.…

1
Webinar: CAR-T Cell Targeted Delivery of Secreted Therapeutics for Solid Tumors 48:30

9d ago48:30

48:30

Creative Biolabs is pleased to invite Dr. Mark Leick to present a novel 'Trojan horse' CAR-T strategy that simultaneously targets tumor cells and delivers localized VEGF blockade to disrupt angiogenesis.antibodybasedpharmaceuticalsresourcelibrary által

1
Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs 1:50

10d ago1:50

1:50

In today’s Pharmaceutical Executive Daily, Novartis plans to eliminate 550 positions at a major Swiss site, the FDA authorizes the first gene therapy for adolescents and adults with spinal muscular atrophy, and industry experts weigh in on how next-generation CDMOs are evolving to meet rapid market change.…

1
Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan 2:03

11d ago2:03

2:03

In today’s Pharmaceutical Executive Daily, Novo Nordisk faces market pressure after a late-stage trial setback, Moderna takes out a $1.5 billion loan to support its long-term growth plan, and Medicare moves closer to releasing negotiated prices for 15 widely used, high-cost medicines.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Tesaro and AnaptysBio's Legal Battle 2:08

12d ago2:08

2:08

In today’s Pharmaceutical Executive Daily, learn how Tesaro is suing AnaptysBio over alleged contract breaches, Flagship Pioneering and Valo Health announce major new collaborations, and why integrated direct-to-patient drug distribution is becoming a strategic imperative.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Novartis' North Carolina Manufacturing Hub 1:40

15d ago1:40

1:40

In today’s Pharmaceutical Executive Daily, learn how Abbott is acquiring Exact Sciences in a major diagnostics deal, Novartis is building a new manufacturing hub in North Carolina, and the FDA is rolling out a wide batch of drug approvals.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Moderna's $140 Million Manufacturing Investment 1:47

16d ago1:47

1:47

In today’s Pharmaceutical Executive Daily, learn how Moderna is expanding its manufacturing footprint in Massachusetts, GSK is advancing new research collaborations under the LTZ Fleming Initiative, and the FDA commissioner highlights how early and late movers can benefit from the National Priority Voucher program.…

1
Pharmaceutical Executive Daily: FDA's Approval of Epkinly 1:39

17d ago1:39

1:39

In today’s Pharmaceutical Executive Daily, learn how Novo Nordisk is launching an introductory offer for Wegovy and Ozempic, AbbVie and Genmab gain FDA approval for Epkinly in follicular lymphoma, and Johnson & Johnson announces a $3 billion definitive agreement to acquire Halda Therapeutics.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure 1:44

18d ago1:44

1:44

In today’s Pharmaceutical Executive Daily learn how Novo Nordisk is restructuring leadership to enhance scientific and commercial alignment, ABL Bio secures a major multi-program partnership with Eli Lilly, and the FDA launches its new Plausible Mechanism Pathway to accelerate drug development.Pharmaceutical Executive Podcast által

1
Epiosde 301: Nashville SC 2.1 1:18:29

19d ago1:18:29

1:18:29

Clay, Stephen and Valair discuss Nashville SC's roster decisions and the upcoming MLS calendar change followed by some big local soccer news. Thanks for listening!Pharmaceutical Soccer által

1
Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval 1:39

23d ago1:39

1:39

In today’s Pharmaceutical Executive Daily, WeightWatchers plans to offer Novo Nordisk’s oral Wegovy pending FDA approval, FDA unveils a new Plausible Mechanism Pathway to accelerate drug reviews, and Ovid Therapeutics and Metagenomi share key third-quarter results and leadership changes.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Dr. Richard Pazdur Appointed as Director CDER 2:05

23d ago2:05

2:05

In today’s Pharmaceutical Executive Daily, Richard Pazdur is named director of FDA’s Center for Drug Evaluation and Research, Pfizer strengthens focus through strategic partnerships and spin-offs, and CMS launches a new initiative to reduce Medicaid drug costs.Pharmaceutical Executive Podcast által

1
How AI Is Accelerating Drug Discovery | Smbat Rafayelyan (Bioneex CEO) 37:37

24d ago37:37

37:37

AI in Drug Discovery | #aidrugdiscovery #biotechinnovation #medicalinnovation Amid a rapidly changing biotech landscape, AI is transforming how we discover and develop new medicines. Please visit our website to get more information: https://swangroup.net/ In this episode, I sit down with Smbat Rafayelyan, founder and CEO of Bioneex, a platform that…

1
Pharmaceutical Executive Daily: AstraZeneca Becomes UK's Largest Stock 2:08

24d ago2:08

2:08

In today’s Pharmaceutical Executive Daily, AstraZeneca surpasses Shell to become the UK’s largest listed company, Basel intensifies efforts to attract international pharma executives, and HHS removes misleading safety warnings from menopausal hormone therapy labels.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Wegovy Shows Potential to Treat MASH Patients 2:11

25d ago2:11

2:11

Pharmaceutical Executive Podcast által

1
Episode 300: 300 Episodes, One Cup 1:14:09

27d ago1:14:09

1:14:09

300 episodes and 1 cup later, our 5th season in MLS comes to an end. Here's to 300 more, thanks for being a part of it!Pharmaceutical Soccer által

1
Raising Biomarker Awareness 11:18

26d ago11:18

11:18

Dr. Jaspal Singh explains some of the barriers that prevent cancer patients from getting biomarker testing early in their treatment journey.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: FDA Approves Darzalex Faspro 2:27

26d ago2:27

2:27

In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Darzalex Faspro for adults with high-risk smoldering multiple myeloma, the industry’s growing interest in direct-to-patient wholesale models, and the FDA’s expansion of its National Priority Voucher program to accelerate review of critical therapies.…

1
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1's to TrumpRX 2:50

29d ago2:50

2:50

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly and Novo Nordisk’s plans to bring their leading weight-loss medications to the TrumpRx platform, the State of Texas’ legal move to block Kenvue’s dividend payment, and the FDA approval of Darzalex Faspro for adults with high-risk smoldering multiple myeloma.…

1
Pharmaceutical Executive Daily: Novo Nordisk's Amended Acquisition Proposal 3:10

1M ago3:10

3:10

In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s amended proposal to acquire Metsera, the State of Texas’ attempt to block Kenvue’s planned dividend payment, and how data and AI are transforming pharma’s next frontier in commercial customer engagement.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue 3:12

1M ago3:12

3:12

In today’s Pharmaceutical Executive Daily, we cover Kimberly-Clark’s $48.7 billion acquisition of Kenvue, Cencora’s $1 billion investment to strengthen U.S. pharmaceutical distribution, and new industry collaborations advancing autoimmune and oncology research pipelines.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk 3:22

1M ago3:22

3:22

In today’s Pharmaceutical Executive Daily, we cover Pfizer’s lawsuits against Metsera and Novo Nordisk over alleged intellectual property infringement, Eli Lilly’s $3 billion investment in a new Netherlands manufacturing site, and the latest wave of biotech partnerships and licensing agreements driving innovation.…

1
Episode 299: Not So Fast 1:06:30

1M ago1:06:30

1:06:30

Join Clay Trainum and Valair Shabilla as they dive into the thrilling world of Nashville SC's playoff journey. In this episode, they discuss the team's recent victory over Inter Miami, the electrifying atmosphere at Geodis Park, and what led to Nashville's success.Pharmaceutical Soccer által

1
Pharmaceutical Executive Daily: George Tidmarsh Resigns from FDA 3:06

1M ago3:06

3:06

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s plan to submit its oral GLP-1 candidate for FDA priority review, the departure of senior FDA official George Tidmarsh, and growing global venture capital investment in biopharma innovation.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal 3:00

1M ago3:00

3:00

In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s unsolicited proposal to acquire Metsera, renewed legal action against Tylenol’s manufacturer following statements from Robert F. Kennedy Jr., and AbbVie’s stronger 2025 profit outlook driven by immunology demand.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Thermo Fisher's $8.8 Billion Acquisition of Clario Holdings 3:04

1M ago3:04

3:04

In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli Lilly’s partnership with Walmart to launch retail pickup for its direct-to-consumer Zepbound program, and the FDA’s new draft guidance aimed at streamlining biosimilar development.…

1
Pharmaceutical Executive Daily: Lilly and NVIDIA Create AI Supercomputer 3:07

1M ago3:07

3:07

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in biotech funding rounds and public offerings, and the FDA approval of Merck’s Winrevair for pulmonary arterial hypertension.Pharmaceutical Executive Podcast által

1
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns 3:03

1M ago3:03

3:03

In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon sales, GSK’s $357 million agreement with Syndivia to expand its antibody-drug conjugate portfolio, and new guidance from the American College of Surgeons classifying obesity as a treatable condition.…

Podcastok, amelyeket érdemes meghallgatni

Pharmaceutical Podcastok

Podcastok, amelyeket érdemes meghallgatni

Gyors referencia kézikönyv